New diabetes clinical trial: Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

Published on: February 28, 2018 at 10:30PM
Condition:   Diabetic Kidney Disease
Interventions:   Drug: TMX-049;   Drug: Placebo
Sponsor:   Teijin America, Inc.
Not yet recruiting
http://ift.tt/2oBDHD4